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The transport of nickel (Ni) across the renal brush border membrane of the rainbow trout was examined in vitro using brush border membrane
vesicles (BBMVs). Both transmembrane transport of Ni into an osmotically active intravesicular space, and binding of Ni to the brush border
membrane itself, were confirmed. Nickel (Ni) uptake fitted a two component kinetic model. Saturable, temperature-dependent transport dominated
at lower Ni concentrations, with a moderate linear diffusive component of Ni transport apparent at higher Ni concentrations. An affinity constant
(Km) for Ni transport within the specifically described vesicular media was calculated as 17.9±1.9 μM, the maximal rate of transport (Jmax) was
calculated as 108.3±3.7 nmol mg protein−1 min−1, and the slope of the linear diffusive component was calculated as 0.049±0.005 nmol mg
protein−1 min−1 per μM of Ni. Efflux of Ni from BBMVs was fitted to an exponential decay curve with a half-time (T1/2) of 125.2±7.3 s. Ni
uptake into renal BBMVs was inhibited by magnesium at a 100:1 Mg to Ni molar ratio, and by magnesium and calcium at a 1000:1 molar ratio. In
the presence of histidine at a 100:1 histidine to Ni ratio, Ni uptake was almost completely abolished. At a 1:1 molar ratio, histidine inhibited Ni
uptake by approximately 50%. Ni–histidine complexation was rapid, with a T1/2 of 12.2 s describing the Ni–histidine equilibration time needed to
inhibit Ni uptake into renal BBMVs by 50%. Characterization of Ni transport across cellular membranes is an important step in understanding
both the processes underlying homeostatic regulation of Ni, and the toxicological implications of excessive Ni exposure in aquatic ecosystems.
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Little is known of the cellular mechanisms of nickel (Ni)
transport in vertebrates. Ni is an essential nutrient for
microorganisms [1], acting as a co-factor in Ni-dependent
enzymes catalyzing cellular reactions critical to energy and
nitrogen metabolism in both prokaryotes and eukaryotes [2].
The essentiality of Ni as a micronutrient in higher vertebrates,
though, has yet to be conclusively determined, despite many
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Ni levels, and inducible Ni deficiency in certain species of birds
and mammals are among the arguments for essentiality in
higher animals [3–6].
For homeostatic regulation of cellular and tissue Ni levels to
occur, animals must have controlled means of uptake and
excretion. Uptake means may be either specific to Ni or non-
specific, typically to a suite of diverse divalent cations. Non-
specific methods of Ni entry into a cell may include the
promiscuous divalent metal transporters DMT1 (also known as
DCT1, Nramp2, or SLC11A2; [7–10]) or Cramp [11],
paracellular transport [12], low affinity magnesium transport
systems such as SLC41A2 [13], corA [14], or MagT1 [15], or
iron absorptive pathways [10,16].
High-affinity, Ni-specific uptake has been documented in
bacteria and yeast, accomplished by ATP-binding cassette
proteins such as NikA-E, found in E. coli [1,17]. Additionally,
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Schizosaccharomyces pombe [2], and the hydrogen bacteria,
Alcaligenes eutropha [18], transport Ni with affinity constants
in the low nanomolar range [1].
To our knowledge, the most in-depth study of cellular Ni
transport in vertebrates used brush border membrane vesicles
(BBMVs) prepared from the small intestine of rabbits [8]. Ni
transport into rabbit intestinal BBMVs was found to be
saturable and temperature dependent. The present report also
uses BBMVs, prepared from rainbow trout kidneys, to
characterize the kinetic properties of piscine Ni transport. The
value of isolated membrane vesicles as a research tool lies with
the ability to manipulate numerous aspects of transport
phenomena in a carefully controlled in vitro setting [19].
All rainbow trout tissues analyzed to date contain a well-
regulated level of Ni on the order of about 5 to 10 μmol kg−1
[20–22]. Rainbow trout urine typically contains 1 μM Ni and
clearance studies have demonstrated that the trout kidney is
capable of highly efficient Ni reabsorption [23]. Such
reabsorption would be useful in a situation of Ni deficiency,
where the trout kidney would be called upon to conserve Ni,
while a condition of Ni excess would presumably stimulate Ni
excretion, potentially via renal secretion, as is the case for Mg2+
during Mg2+ loading experiments in the rainbow trout [24].
Excess Ni loading into the tissues of aquatic animals occurs
readily during exposures to elevated levels of Ni in both the
laboratory [20] and the field [6], where Ni contamination of
freshwaters results from anthropogenic metal loading in
industrial and mining-intensive areas [6].
In addition to characterizing the kinetics of renal BBMV Ni
uptake, we investigated interactions of Ni with the divalent
cations Mg2+ and Ca2+. Ni is known to inhibit voltage-
dependent Ca2+ channels at very high millimolar concentrations
[25], while Ni and Mg act as specific antagonists of one another
in a whole host of systems including bacteria [6,26,27], mold
[28], yeast [29], invertebrates [30], amphibians [31], fish [23],
and mammals [32–38].
The modifying effects of the amino acid histidine on Ni
transport across the renal brush border membrane were also
investigated in light of the prominent role of histidine in plasma
Ni carriage [6,39]. We have previously hypothesized that
formation of Ni–histidine plasma complexes, subject to
glomerular ultrafiltration in vivo, stimulate reabsorption of Ni
at the brush border of the rainbow trout kidney, mediated by a
putative amino acid pathway [6,23,40,41]. In the present study,
we investigated the effects of histidine on Ni transport in vitro,
using BBMV preparations from the rainbow trout kidney.
2. Materials and methods
2.1. Experimental animals
Adult rainbow trout (200–1500 g) of both sexes were obtained from Humber
Springs Trout Farm, Orangeville, ON, Canada. Fish were maintained in the
laboratory for approximately 1 year in 500 L fiberglass tanks served with aerated,
flowing, dechlorinatedHamilton tapwater fromLakeOntario.Water composition
was (in mM) Ca2+=1.0, Mg2+=0.2, Na+=0.6, Cl−=0.8, SO4
2−=0.25, titratable
alkalinity to pH 4.0=1.9. Dissolved organic carbon (DOC) was 3 mg L−1, totalhardness (asCaCO3)was140mgL
−1, pHwas7.9–8.0, and the temperature varied
between 12 and 14 °C.
Fish were fed 1% of their body weight every other day with commercial
trout pellets. The composition of the food was 40% crude protein, 11% crude fat,
3.5% crude fiber, 1.0% calcium, 0.85% phosphorus, 0.45% sodium. The Ni
content of the food was 65 μmol kg−1 dry weight, and the background Ni in
Hamilton tap water was 20–30 nM.
2.2. Preparation of BBMVs
All experimentation was conducted under McMaster University's policy
on the care and use of animals in research, in accordance with the
guidelines of the Canadian Council on Animal Care. Isolation of brush
border membrane vesicles from rainbow trout kidneys followed closely the
protocol of Freire et al. [42], as modified from Schwartz et al. [43]. BBMVs
were prepared from individual fish, with one vesicle preparation per fish.
After fish were euthanized with a blow to the head, approximately 1 g of
kidney was quickly excised and rinsed in ice-cold Ringer solution
containing (in mM) 15 tris(hydroxymethyl)aminomethane (Tris)–HCl, 1.5
CaCl2, 135 NaCl, 2.5 KCl, 1 MgCl2, and 0.5 NaH2PO4, pH 7.85 adjusted
with 0.1 M Tris Base, and osmolality of 293 mosM kg−1. Kidneys were
wrapped in foil, snap-frozen in liquid nitrogen and stored at −70 °C for
fewer than 24 h before vesicle preparation.
Frozen kidneys were minced in 10 mL of ice-cold homogenization
buffer containing 250 mM sucrose, 10 mM triethanolamine–HCl, and 0.1
mM phenylmethanesulfonylflouride (PMSF), pH 7.60 adjusted with 0.1 M
NaOH, and osmolality of 294 mosM kg−1. All subsequent steps were
performed on ice or at 4 °C. Kidney pieces were homogenized gently with 5
strokes of a glass douncer (“loose” pestle), strained through cheesecloth, and
brought up to 35 mL with homogenization buffer. An aliquot of 0.5 mL of
this starting homogenate was snap-frozen for later determination of enzyme
activities.
The steps taken to prepare solutions for ultracentrifugation from this starting
homogenate are diagrammed in Fig. 1. After the initial low speed spin (700×g; 10
min) to pellet non-cellular material, the supernatant was aspirated and
resuspended in fresh homogenization buffer, while the viscous pellet was
added to a separate pool fraction, which was used only for enzymatic analysis.
Starting with the supernatant of this low speed spin, a series of 3 identical
intermediate spins (16,000×g; 20 min) were conducted. Each of these spins
yielded a supernatant, which was reserved for ultracentrifugation, a fluffy pellet,
which was scraped off and resuspended in fresh homogenization buffer to form
the next solution to be centrifuged, and a center pellet, which was added to the
pool fraction. As shown in Fig. 1, supernatants 2, 3, and 4, and the final
suspension of the fluffy pellet in fresh homogenization buffer were then subjected
to ultracentrifugation at 100,000×g for 75 min using an SW 28 rotor and a
Beckman L8-70M ultracentrifuge.
All supernatants from the ultracentrifugation step were aspirated and added
to the pool fraction. The pellets resulting from ultracentrifugation consisted of a
lighter, fluffy outer ring and a dark, firm central core. Measurements of the
activity of selected apical and basolateral marker enzymes revealed that both
parts of the pellet were similarly enriched in the apical marker enzyme when
compared to the starting homogenate, but that the central core pellet was
substantially less enriched in the basolateral marker enzyme than the fluffy outer
pellet (data not shown; see below for marker enzyme enrichments). Accordingly,
the fluffy pellets were scraped and added to the pool fraction, which was then
vigorously stirred before an aliquot of 0.5 mL was removed and snap-frozen for
later analysis of enzyme activities.
To prepare BBMVs, the center ultracentrifugation pellets were scraped and
resuspended in ∼0.6 mL of vesicle buffer containing (in mM) 60 mannitol, 100
NaCl, 50 KCl, 10 N-(2-hydroxyethyl) piperazine-N′-(2-ethanesulfonic acid)
(HEPES), pH 7.40 adjusted with 0.1 M Tris Base, osmolality of 345 mosM kg−1.
The suspension was vesiculated by 50 passages through a 23-gauge needle
[44,45], and the protein concentration of the vesicle solutionwasmeasured by the
method of Bradford [46], after permeabilization with 0.2% Triton-X for 1 min at
room temperature. Vesicle solutionswere thenmade up to a protein concentration
of 0.9 mg mL−1 with vesicle buffer (total volume approximately 1 mL). An
aliquot of 0.135mL of vesicle solution was snap-frozen for later determination of
enzyme activities.
Fig. 1. Schematic representation of the preparation of ultracentrifugation solutions from the starting kidney homogenate. Abbreviations: SN=supernatant; P=pellet;
CP=center pellet; FP=fluffy pellet; HB=homogenization buffer.
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conducted over a 6- to 8-h period immediately following isolation of BBMVs.
Vesicle preparations were stored on ice and aliquoted as needed. There was no
discernable deterioration of the vesicle preparation over the experimental
period.
2.3. Uptake experiments
Uptake of Ni into renal BBMVs was analyzed by the rapid filtration method
of Hopfer et al. [47]. Aliquots of vesicle solution (25 μL) were added to 140 μL
of assay buffer in a 1.5 mL bullet tube equilibrated in a water bath to 12 °C,
which approximated the acclimation temperature of the fish (except in the case
of the Q10 experiments, where 4 °C incubations were used to assess the
temperature dependence of Ni uptake). The assay buffer was simply the vesicle
buffer with ∼37 kBq mL−1 63Ni (NiCl2; Perkin Elmer), and other moieties
added, specific to each experiment. Upon addition of vesicles to radiolabeled
assay buffer (time 0), the reaction tube was immediately vortexed and returned
to the 12 °C water bath. Unless otherwise noted, incubation of BBMVs with
assay buffer was continued for 25 s at 12 °C, at which time uptake of Ni into
BBMVs was terminated by addition of 42 μL aliquots in triplicate to 0.45 μM
methylcellulose membrane filters (ME25; Schleicher and Schuell) in a rapid
filtration manifold (Millipore). Filters were presoaked at 4 °C in a stop/wash
buffer containing (in mM) 20 NiCl2, 100 NaCl, 50 KCl, 20 HEPES, pH 7.40adjusted with 0.1 M Tris Base, osmolality of 333 mosM kg−1. Immediately
following vacuum filtration, filters were washed twice with 2 mL of ice-cold
stop/wash buffer, then placed in 20 mL glass scintillation vials with 2 mL of 1 N
HNO3 (Trace metal grade; Fisher Scientific) for approximately 24 h. After acid
digestion, 10 mL of Ultima-Gold fluor (Packard BioScience) was added and the
filter digested for an additional 48 h. 63Ni radioactivity was measured by liquid
scintillation counting (1217 Rackbeta; LKB Wallac) with quench correction by
the method of external standard ratios.
The kinetics of Ni uptake by renal BBMVs were analyzed by measuring Ni
uptake rate across a range of nominal extravesicular Ni concentrations of 1, 10,
100, 500, and 1000 μM. Actual measured values, as measured by graphite
furnace atomic absorption spectrophotometry (GFAAS; 220 SpectrAA; Varian),
against certified atomic absorption standards (Fisher Scientific), were 3.5, 13.8,
106.4, 467.6, and 976.6 μM. The appropriate extravesicular Ni concentration
was achieved by addition of unlabeled NiSO4d 6H2O.
The temperature dependence of Ni uptake was investigated by uptake
experiments at 4 and 12 °C, at the three lowest extravesicular Ni concentrations
(nominally 1, 10, and 100 μM). Incubations were 30 s at 4 °C and 25 s at 12 °C.
Q10 values were generated from the uptake rates at 4 and 12 °C according to the
formula:
Q10 ¼ ðk2  k1Þ10=ðT2T1Þ ð1Þ
where k refers to the uptake rate and T refers to the incubation temperature.
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Vesicles were preloaded with Ni by 10 min incubation of 25 μL aliquots with
140 μL of assay buffer at 1 μM extravesicular Ni. A 35-μL aliquot of this
reaction solution was then added to 350 μL of (Ni-free) vesicle buffer and efflux
of Ni from vesicles was tracked over 5 min by periodic rapid filtration of 25 μL
aliquots in triplicate.
2.5. Cation competition experiments
Mg2+ or Ca2+, from concentrated stocks of sulfate salts, were added at
concentrations of 10, 100, 1000, and 10,000 μM to assay solutions containing 10
μM extravesicular Ni. Uptake experiments were conducted as described above
to assess the competing influence of these cations on Ni uptake by renal BBMVs
isolated from rainbow trout. Additionally, MgCl2 or Na2SO4 were added at
10,000 μM to 10 μM Ni assay solutions to determine the relative inhibitory
contribution of Mg2+ and SO4
2−.
2.6. Histidine complexation experiments
L- and D-histidine, from concentrated stocks, were added at 100 μM to assay
solutions containing 1 and 100 μM extravesicular Ni to determine whether
histidine mediates Ni uptake into renal BBMVs. These experiments were
conducted both with the standard vesicle preparation lacking a Na+ gradient
(100 mM Na+ in both the vesicle buffer and the extravesicular assay buffer), and
with a few alternate preparations in which pelleted membranes from the center
ultracentrifugation pellet were resuspended and vesiculated in a Na+-free vesicle
buffer containing (in mM) 260 mannitol, 50 KCl, 10 N-(2-hydroxyethyl)
piperazine-N′-(2-ethanesulfonic acid) (HEPES), pH 7.40 adjusted with 0.1 M
Tris Base, osmolality of 347 mosM kg−1. This preparation yielded an inwardly-
directed 100 mM Na+ gradient upon incubation of vesicles in Na-free buffer
with the standard assay buffer containing 100 mM Na+ and radiolabeled Ni.
Once pilot experiments revealed the profound inhibitory effect of L-histidine
on Ni uptake (see below), the effect of equilibration time of Ni and histidine on
Ni uptake was investigated by varying the time between preparation of assay
solutions and subsequent incubation of vesicles in the assay solutions during
uptake experiments. Typically, histidine was added to radiolabeled Ni assay
solutions the evening before uptake experiments were run. In two experiments,
however, this equilibration time was shortened to where histidine and Ni were
combined 2 h and 2 min before uptake experiments were run. These short-term
equilibration experiments were conducted at extravesicular concentrations of 1
μMNi and 100 μM L-histidine, and in the presence of an inwardly-directed 100
mM Na+ gradient.
2.7. Validation of BBMV isolation
Activities of selected apical, basolateral, and mitochondrial marker enzymes
were measured to assess the purity of the BBMV preparation. Alkaline
phosphatase (ALP; EC 3.1.3.1) activity was used as an apical marker and
measured with Sigma reagents according to the protocol of Sigma Technical
Bulletin 104. Na-K-ATPase (EC 3.6.3.9) activity was measured to determine
contamination by basolateral membranes according to the protocol of
McCormick [48], while succinate dehydrogenase (SDH; EC 1.3.99.1) activity
was measured according to the protocol of Flik et al. [49], to assess
mitochondrial contamination of the BBMVs.
Enzyme activities were determined for the starting homogenate, pool
fraction, and vesicle preparation after 1 min incubations of the relevant fraction
with 0.2% Triton-X at room temperature to unmask enzyme activity. For each
enzyme, the activity in the BBMVs, normalized to protein concentration, was
compared to that of the initial homogenate to determine the enrichment of each
membrane fraction.
The integrity of the vesicle preparation was assayed by measuring Ni
accumulation in BBMVs across a wide range of extravesicular osmolalities [44].
Aliquots of vesicle preparations were incubated for 10 min with assay solutions
of 100 μM Ni, adjusted from 105 to 770 mosM kg−1 with D-mannitol.
Osmolality was measured by vapor presume osmometry (Wescor 5100; Wescor,
Inc.). If Ni is taken up into an osmotically active intravesicular space, thenvesicular Ni accumulation should be directly proportional to the intravesicular
space, and therefore inversely proportional to the extravesicular osmolality.
The orientation of the vesicle preparation was analyzed by comparing the
activity of ALP in permeabilized vesicle preparations with that of unpermea-
bilized preparations [44]. In theory, if the BBMV were oriented right-side-out
with the apical brush-border membrane fragments facing out into the
extravesicular solution, enzyme activity should be similar with and without
permeabilization.
2.8. Calculations and statistics
Uptake of Ni into renal BBMVs was calculated according to the formula:
Uptake ¼ cpm
SA
 
=½Pr ð2Þ
where cpm is the average cpm of the 3 filters for each reaction, SA is the
measured specific activity of the assay solution, and [Pr] is the calculated protein
concentration of the assay solution taking into account the measured protein
concentration of the vesicle preparation and the appropriate dilutions. All filter
cpm data were background corrected for non-specific Ni binding to the filters,
determined under each set of experimental conditions. SA (cpm nmol−1) was
calculated using the measured cpm mL−1 of the appropriate assay solution,
determined by β counting, and the total Ni concentration (nmol mL−1) as
measured by GFAAS as described above. Uptake rate in nmol mg protein−1
min−1 was calculated by dividing uptake by the incubation time (typically 25 s).
All kinetic parameters were calculated directly from the lines of best fit within
Sigma Plot 9.0 (SPSS Inc.).
All data were successfully tested for normality (Shapiro–Wilk test) and
equality of variance (F-test for k=2; Levene test for kN2). Data were then tested
for significant differences using either a two-tailed Student's t-test (k=2
treatments), or a one-way ANOVA (kN2 treatments) with either a Bonferroni
post hoc test, or a Dunnett's post hoc test if there was an appropriate control
treatment. Data are expressed as mean±1 S.E.; n=number of individual BBMV
preparations (and therefore, number of fish).
3. Results
3.1. Characterization of the trout kidney BBMV preparation
The protocol used to isolate BBMVs from the kidney of the
rainbow trout yielded a vesicle preparation that was preferen-
tially enriched with an apical enzyme marker when compared to
basolateral and mitochondrial enzyme markers. Enrichment of
the apical enzyme alkaline phosphatase was significantly higher
(Pb0.000001; Student's t-test) than the enrichment of the
basolateral enzyme Na-K-ATPase. When compared to enzyme
activity in the starting homogenate, alkaline phosphatase was
approximately 4-fold higher in the BBMV preparation, as
compared to an enrichment of approximately 2.5-fold for Na-K-
ATPase (Table 1). The mitochondrial marker succinate
dehydrogenase was not enriched by the preparation of
BBMVs (Table 1).
The BBMVs were oriented in a right-side-out fashion, as
evidenced by the ratio of ALP activity in unpermeabilized
vesicle preparations to ALP activity in permeabilized prepara-
tions. ALP activity in unpermeabilized preparations was
110±11.3% (n=11) of that in permeabilized preparations.
3.2. Renal BBMV Ni uptake
The majority of experiments measuring Ni uptake rates by
renal BBMVs were conducted over 25 s uptake periods, during
Table 1
Marker enrichment of BBMVs prepared from rainbow trout kidneys
Enzyme Homogenate Pool fraction MVa MV Enrichment b
Alkaline phosphatase c 119.0±6.5 (37) 152.2±6.9 (36) 407.6±25.7 (33) 3.73±0.22 (33)
Na-K-ATPase d 4.41±0.26 (37) 3.53±0.26 (38) 10.29±0.41 (33) 2.34±0.12 (33)
Succinate dehydrogenase e 0.14±0.02 (12) 0.17±0.02 (12) 0.12±0.01 (12) 0.82±0.12 (12)
Data are presented as mean±S.E. (n)
a MV = membrane vesicles.
b Enrichment refers to the ratio of specific enzyme activity in the membrane vesicle preparation to that of the homogenate.
c IU mg protein−1 h−1.
d μmol ADP mg protein−1 h−1.
e Absorbance at 490 nm (A490) mg protein
−1 h−1.
Fig. 2. Temperature-dependence of Ni uptake rate (nmol mg protein−1 min−1)
into renal BBMVs at varying extravesicular Ni concentrations. Incubations were
for 25 s at 12 °C and 30 s at 4 °C. Asterisk “*” indicates a significantly higher
(Student's t-test) uptake rate at 12 °C than at 4 °C at each Ni concentration. Q10
values were calculated as described in the text. Q10 values not sharing the same
letter are significantly different (one-way ANOVA with Bonferroni multiple
comparison test). Data are presented as mean±S.E. (n=4–5).
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solution (see above). The two exceptions were the temperature-
dependent Q10 experiments, where a 30-s uptake period was
used at 4 °C to ensure sufficient uptake of Ni at the lower
temperature, and the osmolality-dependent accumulation
experiments, where a 10-min incubation was used to ensure
saturation of BBMVs with Ni.
Time course experiments showed that at 12 °C the standard
25 s uptake period was close to the time to half-saturation of Ni
uptake (T1/2), falling within the linear part of the rapid uptake
phase (data not shown). Time-dependent Ni uptake by renal
BBMVs at 1 μM Ni exhibited a hyperbolic pattern, reaching
steady-state by 5 min, and exhibiting a T1/2 of 20.7 s (data not
shown).
Uptake of Ni into the osmotically active intravesicular space
of renal BBMVs was verified by incubating vesicles in
radiolabeled Ni solutions ranging in extravesicular osmolality
from 105 to 770 mosM kg−1. The results of these experiments
(data not shown) suggest that our isolation protocol yielded a
sealed vesicle population, as extravesicular osmolality was
inversely correlated with Ni uptake (R2 =0.87). Because
intravesicular space is inversely related to extravesicular
osmolality, Ni uptake was directly proportional to the volume
of intravesicular space, as would be expected with a population
of sealed vesicles. Extrapolation to an infinite osmolality, with
an assumed lack of any intravesicular space, yielded amembrane
binding component of BBMV Ni uptake of 44.6 nmol mg
protein−1. Uptake, then, was a combination of Ni transported
into an osmotically active intravesicular space and Ni bound to
vesicular membrane.
Ni uptake into renal BBMVs was determined to be
temperature-dependent. At 1, 10, and 100 μM Ni, uptake
rates at 4 °C were significantly lower than uptake rates at 12 °C
(Fig. 2). The Q10 value was concentration dependent, being
significantly higher at 1 and 10 μM Ni than at 100 μM Ni,
where passive diffusion of Ni into BBMVs (following a steeper
concentration gradient) is more likely (Fig. 2). The Q10 value at
1 μM Ni was strongly indicative of energy-dependent transport
processes (∼3.0), falling to only 1.6 at 100 μM Ni.
Ni uptake into renal BBMVs, measured across a range of
[Ni] from 1 to 1000 μM, was fit to a two-component kinetic
model. The two components were saturable, Michaelis–Menten
kinetics prevailing at lower [Ni], and a modest linear diffusive
component prevailing at higher [Ni] (Fig. 3). The plot of Niuptake rate as a function of [Ni] was best described by the
equation:
Uptake rate ¼ Jmax½Ni
Km½Ni þm½Ni ð3Þ
where Jmax is the maximal rate of transport, Km is the
concentration of Ni at which transport is half-maximal, and m
is the slope of the linear diffusive component of Ni uptake.
In the context of the specific vesicular media employed, the
calculated kinetic parameters of Ni uptake into renal BBMVs
were Jmax equal to 108.3±3.7 nmol mg protein
−1 min−1, Km
equal to 17.9±1.9 μM, and m equal to 0.049±0.005 nmol mg
protein−1 min−1 per μM of Ni (Fig. 3).3.3. Efflux of Ni from renal BBMVs
After loading of renal BBMVs with radiolabeled Ni, the time
course of Ni efflux from BBMVs was measured by transfer of
radiolabeled vesicles into Ni-free assay solution. Ni efflux data,
Fig. 5. Influence of Mg2+, Ca2+, and Na2SO4 on Ni uptake rates (nmol mg
protein−1 min−1) into renal BBMVs. Incubations were for 25 s at 12 °C at an
extravesicular concentration of 10 μM Ni. (A) Mg2+ competition (as MgSO4).
Asterisk “*” indicates significantly different from Mg2+-free treatment (One-
2+
Fig. 3. Ni uptake rate (nmol mg protein−1 min−1) into renal BBMVs as a function
of extravesicular Ni concentration. Extravesicular Ni concentrations were
measured, not nominal. Incubations were for 25 s at 12 °C. Data are presented as
mean±S.E. (n=3–5).
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vesicle protein, was arcsine transformed and fitted to an
exponential decay model (Fig. 4).
From the regression equation, T1/2 was calculated as 123.5 s
(Fig. 4). At 12 °C, then, the time to 50% efflux from preloaded
vesicles was approximately six times greater than the time to
half-saturation of uptake into vesicles at an extravesicular
concentration of 1 μM Ni (∼20 s).
3.4. Cation competition experiments
The ability of either Mg2+ or Ca2+ to interfere with renal
BBMV Ni uptake was explored via cation competition
experiments. Inhibition of Ni uptake rate by magnesium, as
MgSO4, was concentration dependent, being significantly
reduced at both 1000 and 10,000 μM Mg2+ (Fig. 5A). As all
cation competition experiments were run at a [Ni] of 10 μM,
significant Mg-induced inhibition of Ni uptake rate occurred at
both a 100:1 and 1000:1 Mg:Ni molar ratio.Fig. 4. Time course of Ni efflux (% remaining of original cpm μg protein−1)
from pre-loaded renal BBMVs at 12 °C. Data are presented as mean±S.E.
(n=5–6). To calculate the T1/2, efflux data were arcsine transformed and fit to an
exponential decay model.
way ANOVAwith a Dunnett's multiple comparison test). (B) Ca competition
(as CaSO4). Asterisk “*” indicates significantly different from Ca
2+-free
treatment (One-way ANOVA with a Dunnett's multiple comparison test). (C)
MgCl2 and Na2SO4 competition. Asterisk “*” indicates significantly different
from control treatment (Student's t-test). Data are presented as mean±S.E.
(n=3–4).Calcium-induced inhibition of Ni uptake rate by renal
BBMVs was not concentration-dependent, and was only
significant at the highest Ca concentration used (Fig. 5B). At
10,000 μM Ca2+ (as CaSO4), inhibition of Ni uptake rate
occurred at a 1000:1 Ca:Ni molar ratio.
The inhibition of Ni uptake rate by MgSO4 and CaSO4 was
cation-dependent and not SO4
2−-dependent, as verified by the
results shown in Fig. 5C. MgCl2 at 10,000 μM significantly
inhibited Ni uptake rate to a similar degree as MgSO4 and
CaSO4, while Na2SO4 (also at 10,000 μM) had no significant
effect on the rate of Ni uptake.
Fig. 7. Influence of Ni-L-histidine equilibration time on Ni uptake rates (cpm mg
protein−1 min−1) into renal BBMVs at 12 °C. Extravesicular Ni and L-histidine
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Addition of L-histidine to the radiolabeled Ni solution prior
to uptake experiments had a drastic effect on Ni uptake rates
when L-histidine was present at a hundred-fold excess of Ni
(Fig. 6A). At 100 μM L-histidine and 1 μMNi, uptake into renal
BBMVs was essentially abolished. At this His:Ni ratio of 100:1,
near-complete abolition of Ni uptake rate persisted with both L-
and D-histidine, and with or without a 100 mM inwardly
directed Na+ gradient (Fig. 6A). Additionally, short-term pre-
equilibration of L-histidine with Ni also resulted in an almost
undetectable rate of Ni uptake (Fig. 6A; see below).
At a 1:1 His:Ni molar ratio, inhibition of Ni uptake rate was
still substantial, though not nearly as profound (Fig. 6B).
Histidine-induced inhibition of Ni uptake rate at a 1:1 molar
ratio was approximately 47 to 52%, with only slight, non-Fig. 6. Influence of 100 μM L- or D-histidine on Ni uptake rates (nmol mg
protein−1 min−1) into renal BBMVs. Incubations were for 25 s at 12 °C at an
extravesicular concentration of either 1 or 100 μM Ni. 100 mM Na+ gradient
refers to an inwardly directed Na+ gradient (i.e., extra- to intra-vesicular). (A) 1
μMNi. “2 h Eq.” and “1 min Eq.” refer to the time allowed for pre-equilibration
of Ni and histidine prior to uptake experiments (see text for details). Asterisk “*”
indicates significantly different from control treatment (Student's t-test). (B) 100
μM Ni. Asterisk “*” indicates significantly different from control treatment
(Student's t-test). Data are presented as mean±S.E. (n=3–5).
concentrations were 1 μM and 100 μM, respectively. Included in the total Ni–
histidine equilibration times are the 25 s incubation period of radiolabeled Ni–
histidine solutions with BBMVs. The time course was fitted to a curve of
exponential decay. Data are presented as mean±S.E. (n=3).significant variation depending on the histidine isomer or the
presence of an inwardly directed Na+ gradient.
The solutions used in the histidine competition studies were
typically made by addition of histidine to radiolabeled Ni
solutions the evening before the appropriate uptake experiment
was conducted. The kinetics of putative Ni–histidine complex-
ation were investigated by greatly shortening the equilibration
time prior to running uptake experiments. At 100 μM L-
histidine and 1 μM Ni, and in the presence of a 100 mM
inwardly directed Na+ gradient, uptake experiments were run
after a 2 h and an approximate 2 min equilibration time (Fig.
6A). Shortening the time available for Ni–histidine interaction
prior to uptake experiments, however, had no substantial effect
on Ni uptake (Fig. 6A), as rates of uptake were still inhibited by
approximately 99% at the shorter incubation times.
There was, however, a very subtle time-dependent effect
noticeable only at the shortest possible equilibration times.
Accordingly, the inhibitory effects of Ni–histidine complexa-
tion on renal BBMV Ni uptake were investigated during the
shortest resolvable time period. A time course of Ni uptake
(measured as cpm per μg vesicular protein) was measured
following Ni–histidine equilibration periods ranging from
approximately 0 to 3 min (Fig. 7). The decrease in Ni uptake
with increased time of equilibration of Ni and histidine was
exponential, with an equilibration time to 50% inhibition of Ni
uptake of only 12.2 s.
4. Discussion
4.1. Characterization of BBMVs prepared by sucrose
precipitation
A sucrose precipitation method was used to isolate BBMVs
in order to avoid the confounding effects of preparation viaMg2+
or Ca2+ precipitation, techniques which require addition of
molar quantities of these cations to the membrane preparation.
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who measured Mg2+ uptake into rainbow trout BBMVs. Given
the literature documenting antagonistic effects between Ni and
Mg2+ and Ni and Ca2+ (see above), and our in vitro
investigations of cation competition, we similarly wished to
avoid contamination of BBMVs with excessive levels of Mg2+
and Ca2+. Accordingly, the enzyme enrichments presented in
Table 1 are similar to those described by Freire et al. [42].
4.2. Characterization of Ni uptake by renal BBMVs
In a very detailed set of studies measuring Ni uptake by
BBMVs prepared from rabbit small intestine, Knopfel et al. [8]
concluded that Ni uptake was rapid and resolvable into two
components. Using two separate calcein fluorescence assays,
these authors were able to quantify the amount of Ni binding to
the BBM versus the amount of Ni transported across the BBM
into the vesicular space. A calculated half-time to saturation of
20 s was associated with that needed to half-saturate non-
specific binding to the BBM, while a longer T1/2 associated with
transmembrane transport was estimated by Knopfel et al. [8] at
approximately 2 min.
While we have not separated transmembrane transport from
membrane binding in the present study, our osmolality
experiments (see Results section) confirm that Ni uptake was
proportional to intravesicular space, demonstrating the presence
of transmembrane transport. A distinct membrane binding
component, however, was also present. Additionally, the 20 s
T1/2 calculated for Ni uptake in the present study (data not
shown) matches very closely the T1/2 for membrane binding
from Knopfel et al. [8], while the 2 min T1/2 associated with
transmembrane transport agrees fairly well with our uptake data
(data not shown).
Due to the presence of both transmembrane transport and
membrane binding, the following conclusions generated from
the data of Figs. 2 through 7 will be discussed in the context of
the two possible fates of Ni associated with renal BBMVs. This
interpretation is consistent with the results of our osmolality
experiments showing both processes occurring, and the data of
Knopfel et al. [8] reporting that Ni bound to rabbit intestinal
BBMs was a linear function of the extravesicular Ni
concentration, accounting for up to 40% of the total Ni
associated with BBMVs.
Generally, the data of Figs. 2 and 3 describe temperature-
dependent Ni transport with a saturable component, and a lesser
diffusive component dominating at higher extravesicular Ni
concentrations. The Q10 value of approximately 3 at an
extravesicular [Ni] of 1 μM (Fig. 2), in particular, was very
suggestive of energy-mediated transport processes. There was,
however, no obvious energy source in these BBMV prepara-
tions, as they were both ATP-free and predicted to have no
discernible transmembrane potential (in most experiments,
including the temperature-dependent assays, the intra- and
extra-vesicular buffers were identical in all ways except the
presence of low concentrations of Ni in the extravesicular
buffer). As all BBMVs were Ni-free prior to uptake experi-
ments, Ni transport into BBMVs was always down aconcentration gradient and the relatively large Q10 value
observed at 1 μM Ni is likely indicative of a transport process
strongly dependent on facilitated, or carrier-mediated, diffusion
[50].
Similar characteristics of temperature-dependent Ni trans-
port were also observed in vitro across monolayers of human
intestinal Caco-2 cells [12]. Additionally, in perfused intestinal
segments of the rat, Ni absorption was temperature-dependent
and saturable [51], suggesting a level of consistency in Ni
transport across both tissues and taxa.
It was predominately at extravesicular Ni concentrations of
less than 100 μM that Ni uptake was more strongly
characteristic of saturable, carrier-mediated diffusion (Figs. 2
and 3). At 100 μM and higher, simple physical diffusion
appeared to contribute to Ni uptake by BBMVs.
Taking into consideration, though, the two possible associa-
tions of Ni with both the BBM itself and the vesicular space of
BBMVs, Ni uptake at low extravesicular Ni concentrations may
also include Ni bound to the BBM. Additionally, at higher Ni
concentrations, Ni binding to the BBM may supplement
transmembrane transport and physical diffusion across the
BBM.
In microorganisms, transmembrane transport of Ni occurs
non-specifically via transport systems for other cations, such as
that for Mg2+ in the fission yeast, S. pombe [2]. Additionally, in
the anaerobe, Clostridium pasteurianum, Ni transport via a Mg
pathway was indirectly evidenced by profound inhibition of Ni
transport by Mg [52]. Though somewhat weaker in the present
study, concentration-dependent, Mg-induced inhibition of Ni
transport into renal BBMVs (Fig. 5A) may similarly be
indicative of non-specific transport of Ni by a low affinity,
high capacity Mg2+ transport system. Such a Mg2+ transport
system may be similar to the electrodiffusive Mg2+ pathway
described by Freire et al. [42], using renal BBMVs from
rainbow trout prepared by a sucrose precipitation method very
similar to that adopted in the present study.
At 10 μM Ni and 1000 μM Mg2+, concentrations similar
to those found in rainbow trout blood (∼5 μM Ni; 1000 μM
Mg2+) and urine (∼1 μM Ni; 1000 μM Mg2+), BBMV Ni
uptake was significantly inhibited by 21%. Inhibition of Ni
uptake into renal BBMVs was also significant at 10,000 μM
Mg2+ and Ca2+, though inhibitory effects at these supraphy-
siological concentrations of Mg2+ and Ca2+ may be mediated
by secondary effects of these cations on membrane perme-
ability, as increased levels of Mg2+ and Ca2+ associated with
epithelia decrease membrane permeability [53]. Inappropriate
aggregation of membranes, stimulated by such high concen-
trations of these cations may also indirectly limit Ni uptake
by reducing the available membrane surface area available for
transport.
Alternatively, some fraction of the Mg2+ -induced inhibitory
phenomenon may be occurring at the membrane binding level,
with Mg2+ (or Ca2+ at 10,000 μM) displacing Ni2+ from the
BBM. Both Mg2+ and Ca2+ bind to the BBM with high affinity,
a phenomenon exploited in the commonly used method of
BBMV preparation by either Mg2+ or Ca2+ precipitation (for a
review of this technique, see ref. [54]).
Table 2
Ni speciation in histidine-free and histidine-containing assay solutions
[Ni] (μM) Ni2+ NiCl+ Ni(His)2 Ni(His)
+
Ni alone 1 89.2 10.7 0 0
100 89.2 10.7 0 0
100 μM histidine 1 0 0 94.6 5.4
100 10.1 1.2 10.6 78.1
Ni speciation was calculated using the geochemical speciation program
MINEQL+ (Ver. 4.5, Environmental Research Software). Values for the
different Ni species are given as percentage of total Ni.
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inhibition of Ni uptake by renal BBMVs was far from complete,
indicating Mg-independent Ni uptake pathways in the renal
epithelium of the rainbow trout. Such pathways may include
those for iron absorption, as documented for the rat intestine,
and mediated by the divalent metal transporter (DMT1) [10,16].
4.3. Efflux of Ni from BBMVs
The predominant route of blood Ni excretion in mammals is
via the urine [6], whether it be Ni absorbed through the
gastrointestinal tract [55,56], or introduced into the blood via
experimental injection [57–59]. During chronic, low-level
waterborne Ni exposure, however, Ni continued to be
reabsorbed by the trout kidney despite extensive Ni accumu-
lation in urine and renal tissue, suggesting a very inefficient, or
non-existent, secretory capacity in rainbow trout [23].
When compared to Ni uptake into renal BBMVs (simulating
reabsorptive apical to basolateral transport; efflux of Ni from
renal BBMVs (simulating secretory basolateral to apical
transport) was substantially slower. It is not known, however,
to what extent efflux from BBMVs represents transmembrane
loss of intravesicular Ni, or dissociation of Ni from the external
BBM surface itself. Further experiments investigating the
temperature dependence of Ni efflux may prove useful in
teasing apart these two possibilities.
4.4. Histidine complexation experiments
The results of the histidine complexation experiments
(Fig. 6) are diametric to our hypothesis, and potentially
contradict one of the prevailing models of mammalian
cellular Ni uptake. Ni putatively crosses cell membranes as a
low molecular weight L-histidine nickel complex [6,40,41].
Addition of L-histidine to 63Ni radiolabeled assay solutions
prior to uptake experiments was hypothesized to stimulate Ni
uptake into BBMVs, as was shown for Zn uptake into
BBMVs prepared from rainbow trout intestine [44]. Instead,
at a 100:1 histidine to Ni ratio, uptake, including both
components of membrane association and transmembrane
transport, was essentially abolished (Fig. 6A).
Addition of both a physiological (L-) and non-physiological
(D-) isomer of histidine had the same effect, suggesting that both
isomers rendered Ni almost completely unavailable for BBM
binding and transmembrane transport. The latter point is
reinforced by the lack of effect of a 100 mM inwardly directed
Na+ gradient, designed to stimulate Na-dependent amino acid
symport into the vesicular space of renal BBMVs (Fig. 6A).
The speciation of Ni in the various histidine-containing assay
solutions was calculated and compared to Ni speciation in
histidine-free assay solutions (Table 2). Although the affinity
constants employed in these calculations are subject to some
uncertainty due to possible buffer complexation in the vesicular
media, these speciation estimates facilitate a mechanistic
interpretation of the histidine-mediated uptake data.
If Ni uptake into renal BBMVs were purely a function of the
concentration of free Ni2+, the change from 89.2% Ni2+ at 1 μMNi to essentially no Ni2+ at 1 μM Ni plus 100 μM histidine
(Table 2) would explain the near abolition of Ni uptake upon
addition of 100 μM histidine (Fig. 6A). At a 100:1 histidine to
Ni ratio, almost 95% of the available Ni was in the form of the
bis-chelated complex (Ni(His)2), while the other 5% was
complexed as a mono-histidine species (Table 2).
The data of Fig. 6, however, are not completely inconsistent
with putative uptake of Ni via a histidine-mediated pathway.
From the speciation calculations, over 97% of the available
histidine at a 100:1 histidine to Ni ratio was unchelated (data not
shown). In this interpretation, Ni moves through a histidine
transporter, as either a mono- or bis-chelated histidine complex,
but was outcompeted by the near 100-fold excess of available
free histidine. This alternate explanation, however, is not well
supported by the isomer effect, whereby the non-physiological
(D-) isomer should be poorly transported, thereby relaxing the
competition by free histidine. Indeed, the presence of 97% free
D-histidine had the same inhibitory effect as the excess of free L-
histidine (Fig. 6A). If one assumes, however, that excess free
histidine blocks Ni transport, without being itself transported,
then isomer (and Na gradient) independent inhibition of Ni
transport may be occurring.
At a 1:1 histidine to Ni ratio (100 μM histidine and 100 μM
Ni), approximately 11% of the Ni was present in the bis-chelated
form, and 78% in the mono-chelated form (Table 2). Free Ni2+
accounted for the remaining 10–11% of the total Ni. At this 1:1
molar ratio of histidine to Ni, all of the available histidine was
complexed to Ni in one form or another (data not shown),
potentially relaxing the free histidine mediated competitive
inhibition of transport of a Ni–histidine complex via a histidine
transporter. In this interpretation, the approximate 50% inhibi-
tion of Ni uptake by renal BBMVs (Fig. 6B) was then a function
of speciation, with either the mono- or bis-chelated species being
favorable (or unfavorable) for transport in the absence of
competing free histidine. Interestingly, using extravesicular
zinc–histidine solutions for Zn transport work with trout
intestinal BBMVs, Glover et al. [44] showed that the mono-
chelated form Zn(His)+ was best correlated to zinc uptake. A
detailed investigation of the concentration dependence of
histidine-mediated inhibition of Ni transport would be of great
interest to determine whether either histidine–Ni complex is
readily transported across the renal BBM of the rainbow trout.
Standing concentrations of histidine and Ni in the plasma of
rainbow trout are typically about 100 μM [60] and 3 μM [20],
respectively. In the urine, a similar ratio of approximately 100:1
is not unlikely. The inherent complications of extrapolating in
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suggest that at this typical 100:1 ratio, histidine-mediated in
vivo transport of Ni across the renal BBM is not an important
route. However, in times of extensive urine loading of Ni, and/
or decreased urine levels of histidine, resulting in marked
reductions in the histidine to Ni ratio, histidine-meditated
pathways may account for some of the potentially counterpro-
ductive reabsorption of Ni across the renal BBM.
4.5. Histidine–Ni equilibration times and Ni uptake into renal
BBMVs
The detailed time course of histidine–Ni association showed
that 12 s was sufficient to render half of the Ni unavailable for
uptake by, or binding to, renal BBMVs (Fig. 7). If histidine–Ni
solutions (at a 100:1 ratio) were left to equilibrate anywhere
from 3 min to 24 h, near complete abolition of Ni uptake was
consistent. Ni is typically classified as a very slow ligand
exchanger compared to other transition metals [61,62], and it
would be of interest to investigate the effect of competing
ligands on the uptake-suppressing complexation of Ni by
histidine. Given the relative affinity of Ni for histidine (see ref.
[6] for a review), and the kinetics of Ni exchange, we
hypothesize that histidine-induced inhibition of Ni uptake by
renal BBMVs is refractive to short-term manipulations of
competing ligands.
5. Conclusions
The data presented herein, along with that of Knopfel et al.
[8] represent initial steps towards understanding transmembrane
Ni transport by vertebrate epithelia. More detailed knowledge of
the mechanisms of cellular Ni transport, and the processes
regulating such transport, may shed light on the pathophysiol-
ogies associated with exposure to elevated levels of Ni.Acknowledgments
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